Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat - 24/7 Wall St.
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat 24/7 Wall St.
Covered in this story
What has happened since
- Moderna is down 2.7% since this was published, 6 days ago.
- Pfizer is down 3.6% since this was published, 6 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Citi’s $80 target on $MRNA is on the record and being tracked to Sep 2027 (12-month default), scored on the close that day.
Citi’s track record →Analyst targets on Moderna
- Morgan Stanley: $174 → $89 by Aug 2027 · Equalweight via Investing.com
- Bank of America: $174 → $170 by Aug 2027 · Neutral via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MRNA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Moderna →Summary aggregated from Google News's public RSS feed. The full reporting belongs to Google News — please read it on their site.